RxDoctor Payments Data

Anil Ram, MD

Gastroenterology · Crystal River, FLNPI 1346272549

Payments from drug & device makers

$1,731in general payments, 2019–2025

Across 91 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$763
  • Nestle Healthcare Nutrition Inc.$121
  • Johnson & Johnson$106
  • Bristol Myers Squibb$102
  • Fujifilm Healthcare Americas Corporation$100
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$97
  • plus $442 from 17 others

What the payments were for

  • Food & beverage$1,731100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,731 in reported general payments places this provider in the 30th percentile of 1,388 gastroenterology providers in Florida.

See all gastroenterology providers in Florida

Medicare billing

Part B allowed, 2024
$427,254
Medicare patients
1,021
Services billed
3,807

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase16$57,742
ClenpiqSod Picosulf/Mag Ox/Citric Ac303$51,660
LinzessLinaclotide31$36,022
Pantoprazole Sodium791$14,036
Mesalamine21$13,339
Budesonide DrBudesonide38$5,722
MovantikNaloxegol Oxalate15$5,438
CholestyramineCholestyramine (With Sugar)58$4,028
Famotidine207$3,761
Colesevelam Hcl48$3,439
Colestipol Hcl66$3,191
Lubiprostone15$1,807
Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl94$1,747
Ondansetron Hcl50$1,264
Sucralfate27$1,042

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$763$93,76447 claims
Redhill Biopharma Inc.Movantik$17$5,43815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 1,388 gastroenterology providers in Florida.

Other gastroenterology in Crystal River

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →